loadpatents
Patent applications and USPTO patent grants for Hilgard; Peter.The latest application filed is for "novel phospholipid derivatives".
Patent | Date |
---|---|
Disease treatment with novel phospholipid derivatives Grant 6,903,080 - Nossner , et al. June 7, 2 | 2005-06-07 |
Use of dopamine receptor antagonists in palliative tumor therapy Grant 6,696,428 - Nickel , et al. February 24, 2 | 2004-02-24 |
Novel phospholipid derivatives App 20030153533 - Nossner, Gerhard ;   et al. | 2003-08-14 |
Solid pharmaceutical compositions containing hexedecylphosphocholine (miltefosine) for oral administration in the treatment of leishmaniasis Grant 6,544,551 - Engel , et al. April 8, 2 | 2003-04-08 |
Pharmaceutical composition comprising ifosfamide and carnitine App 20030040507 - Nickel, Bernd ;   et al. | 2003-02-27 |
Use of dopamine receptor antagonists in palliative tumor therapy App 20030008846 - Nickel, Bernd ;   et al. | 2003-01-09 |
Long-acting injection suspensions and a process for their preparation Grant 5,773,032 - Engel , et al. June 30, 1 | 1998-06-30 |
Salts of oxazaphosphorine derivatives Grant 4,716,242 - Engel , et al. December 29, 1 | 1987-12-29 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.